Overview

A focused overview of the role of IL‑13 in the pathophysiology of atopic dermatitis, highlighting its impact on inflammation and skin barrier dysfunction. Educational content intended for healthcare professionals.

This Class for

Physician
Resident / Fellow

What I will learn?

Understand key immune mechanisms driving atopic dermatitis, with focus on type 2 inflammation.
Explain the role of IL‑13 in skin barrier disruption and inflammatory signaling in AD.
Recognize the clinical relevance of IL‑13 as a therapeutic target in atopic dermatitis.

Disclaimer

This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
(This information/content is intended to Health Care Providers only)

For adverse events and safety reporting: email: [email protected]

24 /7 mobile: +966 567 868 843, Working hours Tel: +966 11 461 7800 , Ext: 1

For Lilly product information: email: [email protected]

For further information, please contact:

Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: [email protected]
Please go to PDF Material for prescribing information.

PP-LK-SA-0198